Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024

Rhea-AI Summary

Castle Biosciences (Nasdaq: CSTL) has announced the release of its financial results for Q2 and H1 2024 on Monday, Aug. 5, 2024, after market close. The company, which specializes in innovative health tests for patient care, will host a conference call and webcast at 4:30 p.m. Eastern time on the same day to discuss the results.

Investors can access the live webcast through the provided link or via the company's Investor Relations page. For those joining by phone, the U.S. dial-in number is 1 833 470 1428, with international numbers available. The access code for both is 802518. A Q&A session will follow management's commentary, and a replay of the webcast will be available after the call.

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024.

Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.

Conference Call and Webcast Details

A live webcast of the conference call can be accessed here: https://events.q4inc.com/attendee/952012940, or via the webcast link on the Investor Relations page of the Company’s website: https://ir.castlebiosciences.com/overview/default.aspx. Please access the webcast at least 10 minutes before the conference call start time. A replay of the webcast will be available following the conclusion of the conference call.

To access the live conference call via phone, please dial 1 833 470 1428 from the United States, at least 10 minutes prior to the start of the call, using the access code 802518. International dial-in numbers are available here: https://www.netroadshow.com/events/global-numbers?confId=67435; please use the same access code above to join the call.

There will be a brief Question and Answer session following management commentary.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240715107385/en/

Investor Contact:

Camilla Zuckero

czuckero@castlebiosciences.com

Media Contact:

Allison Marshall

amarshall@castlebiosciences.com

Source: Castle Biosciences Inc.

FAQ

When will Castle Biosciences (CSTL) release its Q2 2024 financial results?

Castle Biosciences (CSTL) will release its Q2 2024 financial results on Monday, August 5, 2024, after the market closes.

What time is Castle Biosciences' (CSTL) Q2 2024 earnings call scheduled for?

Castle Biosciences' (CSTL) Q2 2024 earnings call is scheduled for 4:30 p.m. Eastern time on Monday, August 5, 2024.

How can investors access Castle Biosciences' (CSTL) Q2 2024 earnings call?

Investors can access Castle Biosciences' (CSTL) Q2 2024 earnings call via webcast or phone. The webcast link is available on the company's Investor Relations page, and the U.S. phone number is 1 833 470 1428 with access code 802518.

Will there be a Q&A session during Castle Biosciences' (CSTL) Q2 2024 earnings call?

Yes, Castle Biosciences (CSTL) has stated that there will be a brief Question and Answer session following management commentary during the Q2 2024 earnings call.